Salima Benbarche - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Salima Benbarche

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Leukemia|December 30, 2022

High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemiaZakia Aid, Elie Robert, Cécile K Lopez, et al.

Molecular Cell|April 30, 2024

GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignanciesSalima Benbarche, Jose Mario Bello Pineda, Laura Baquero Galvis, et al.

Cancer Discovery|July 29, 2022

Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic TransformationSisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, et al.

Blood|January 26, 2026

Oncogenic SF3B1 mutations alter the splicing of mRNA noncoding regions to induce a novel therapeutic vulnerabilityMichal Sekrecki, Agata Sekrecka, Rohan R Lattupally, et al.

Cancer Cell|October 24, 2025

RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibitionEli L Diamond, Jean-Francois Emile, Takeshi Fujino, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Leukemia|December 30, 2022

High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemiaZakia Aid, Elie Robert, Cécile K Lopez, et al.

Molecular Cell|April 30, 2024

GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignanciesSalima Benbarche, Jose Mario Bello Pineda, Laura Baquero Galvis, et al.

Cancer Discovery|July 29, 2022

Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic TransformationSisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, et al.

Blood|January 26, 2026

Oncogenic SF3B1 mutations alter the splicing of mRNA noncoding regions to induce a novel therapeutic vulnerabilityMichal Sekrecki, Agata Sekrecka, Rohan R Lattupally, et al.

Cancer Cell|October 24, 2025

RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibitionEli L Diamond, Jean-Francois Emile, Takeshi Fujino, et al.

Pageof 2